Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 149 of the 150 references it cites were found in a registry or an index.

The other face of depression, reduced positive affect: the role of catecholamines in causation and cure

Nutt, David, Demyttenaere, Koen, Janka, Zoltan, Aarre, Trond, Bourin, Michel, Canonico, Pier Luigi, Carrasco, Jose Luis, Stahl, Steven · 2007 · Journal of Psychopharmacology

Abstract

Despite significant advances in pharmacologic therapy of depression over the past two decades, a substantial proportion of patients fail to respond or experience only partial response to serotonin re-uptake inhibitor antidepressants, resulting in chronic functional impairment. There appears to be a pattern of symptoms that are inadequately addressed by serotonergic antidepressants — loss of pleasure, loss of interest, fatigue and loss of energy. These symptoms are key to the maintenance of drive and motivation. Although these symptoms are variously defined, they are consistent with the concept of `decreased positive affect'. Positive affect subsumes a broad range of positive mood states, including feelings of happiness (joy), interest, energy, enthusiasm, alertness and selfconfidence. Although preliminary, there is evidence to suggest that antidepressants that enhance noradrenergic and dopaminergic activity may afford a therapeutic advantage over serotonergic antidepressants in the treatment of symptoms associated with a reduction in positive affect. Dopaminergic and noradrenergic agents, including the dual acting norepinephrine and dopamine re-uptake inhibitors, have demonstrated antidepressant activity in the absence of serotonergic function, showing similar efficacy to both tricyclic and serotonin re-uptake inhibitor antidepressants. Moreover, the norepinephrine and dopamine re-uptake inhibitor bupropion has been shown to significantly improve symptoms of energy, pleasure and interest in patients with depression with predominant baseline symptoms of decreased pleasure, interest and energy. Focusing treatment on the predominant or driving symptomatology for an individual patient with major depression could potentially improve rates of response and remission.

Overview

Integrity signals

Registry

Crossref · 10.1177/0269881106069938

Cites

149 of 149 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 150 references

Research works printed but not linked: 32

  1. Alonso J., 2000, Acta Psychiatr Scand, 109, 21
  2. Alonso J., 2000, Acta Psychiatr Scand, 109, 38
  3. Baldwin D.S., J Clin Psychiatry
  4. Bourin M., 1999, Encephale, 25, 21
  5. Bremner J.D., 1984, J Clin Psychiatry, 45, 56
  6. Brothers L., 1995, Neurophysiology of the perception of intentions by primates
  7. Clerc, G.E., 1994, Psychopharmacol, 9, 139
  8. Delgado P.L., 2000, J Clin Psychiatry, 61, 7
  9. Delgado P.L., 2004, J Clin Psychiatry, 65, 25
  10. Demyttenaere K., 2004, Int J Neuropharmacol, 8, 93
  11. Fava M., 2005, J Clin Psychiatry, 7, 106
  12. Feighner J.P., 1991, J Clin Psychiatry, 52, 329
  13. 10.1002/(sici)1098-2396(20000601)36:3<205::aid-syn5>3.0.co;2-d · DOI · Paper page
  14. Hoehn-Saric R., 1991, J Clin Psychiatry, 52, 131
  15. Jamerson B., 2003, Psychopharmacol Bull, 37, 67
  16. Jefferson J.W., J Clin Psychiatry
  17. Maurice-Tison S., 1998, Br J Gen Pract, 48, 1245
  18. Montgomery S.A., 1997, J. Psychopharmacol, 11, S9
  19. Nelson J.C., 2005, Psychiatry, 13, 520
  20. Nemeroff C.B., 2002, Psychopharmacol Bull, 36, 106
  21. Nierenberg A.A., 2001, J Clin Psychiatry, 62, 5
  22. 10.1002/(sici)1520-6394(1996)4:6<312::aid-da7>3.0.co;2-d · DOI
  23. Sitland-Marken P.A., 1990, J Clin Psychiatry, 51, 68
  24. Stahl S.M., 2003, J Clin Psychiatry, 64, 6
  25. Stahl S.M., 2004, J Clin Psychiatry, 6, 159
  26. Thase M.E., 2003, J Clin Psychiatry, 64, 3
  27. Tylee A.T., 1993, Br J Gen Pract, 43, 327
  28. Tylee A., 1999, Int Clin Psychopharmacol, 14, 139
  29. 10.1037/0022-3514.47.1.127 · doi:10.1037/0022-3514.47.1.127 · Paper page
  30. 10.1037/0021-843x.104.1.15 · DOI · Paper page
  31. Willner P., 1995, Adv Biochem Psychopharmacol, 49, 19
  32. Willner P., 2000, Dopaminergic mechanisms in depression and mania

Cited by

See all 384

Metadata

Authors
Nutt, D., Demyttenaere, K., Janka, Z., Aarre, T., Bourin, M., Canonico, P. L., Carrasco, J. L., & Stahl, S.
Affiliations
  • University of Bristol (GB)
  • UZ Gasthuisberg, Adult and Geriatric Psychiatry, Belgium
  • Department of Psychiatry, University of Szeged, Hungary
  • Nordfjord Psychiatric Centre, Sjukehusvegen
  • Faculté de Médecine Pharmacologie Clinique, France
  • Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
  • Carrasco Department of Clinical Psychiatry, U. Complutense de Madrid, Hospital Universitario Clinico San Carlos de Madrid, Spain
  • Neuroscience Education Institute (US)
Corresponding author
Nutt, David
Venue
Journal of Psychopharmacology
Published
2007-07
Volume
21
Issue
5
Pages
461-471
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2115714588
Cited by
366
References
150
Citations by year
2026: 7 · 2025: 8 · 2024: 12 · 2023: 15 · 2022: 22 · 2021: 27 · 2020: 15 · 2019: 22 · 2018: 24 · 2017: 16 · 2016: 30 · 2015: 27 · 2014: 30 · 2013: 19 · 2012: 22
FWCI
1.05
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
GlaxoSmithKline
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
depression, catecholamines, noradrenergic antidepressants, bupropion, serotonin reuptake inhibitors, treatment-resistant depression, anergia, fatigue, motivation, antidepressant response
MeSH terms
Affect, Antidepressive Agents, Catecholamines, Depressive Disorder, Major, Major Depressive Disorder, Dopamine, Humans, Norepinephrine, Remission Induction, Serotonin, Neurotransmitter Uptake Inhibitors, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Patient Selection, Adrenergic Uptake Inhibitors, Dopamine Uptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. https://app.cochat.ai/papers/10.1177/0269881106069938
The paper
Nutt, D., Demyttenaere, K., Janka, Z., Aarre, T., Bourin, M., Canonico, P. L., Carrasco, J. L., & Stahl, S. (2007). The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. Journal of Psychopharmacology. https://doi.org/10.1177/0269881106069938

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.